FierceBiotech delivers the latest news, articles, and resources on clinical trials, drug discovery, FDA regulations, biotech company deals, and more. It caters to senior executives and clinical operations leaders in biotech, pharmaceuticals, and drug development companies. The publication covers topics such as drug development, regulatory compliance, licensing agreements, mergers and acquisitions, and industry deals. FierceBiotech is headquartered in Washington and is the largest and most widely read biotechnology news publication globally.